Perioperative Management of Enoxaparin for Thromboprophylaxis

General Recommendations

The American College of Chest Physicians recommends that enoxaparin thromboprophylaxis should be discontinued on the day of surgery, with the last dose administered at least 24 hours before low-risk bleeding procedures and 48 hours before high-risk bleeding procedures 1, 2
The European Heart Journal states that perioperative interruption of anticoagulants is necessary to minimize the risk of bleeding while maintaining protection against thromboembolic events 1
The European Society of Cardiology notes that enoxaparin has a predictable anticoagulant effect, allowing for temporary suspension before surgical procedures 2

For low-risk bleeding procedures, the European Heart Journal recommends suspending the last dose of enoxaparin thromboprophylaxis 24 hours before the procedure 3, 4
Examples of low-risk procedures include dental extractions, minor dermatological surgery, cataract surgery, and endoscopies without biopsy 3
For high-risk bleeding procedures, the American College of Chest Physicians recommends suspending the last dose of enoxaparin thromboprophylaxis 48 hours before the procedure 1, 2
Examples of high-risk procedures include neurosurgery, complex urological surgery, cardiovascular surgery, and procedures with neuroaxial anesthesia 5

For patients with renal insufficiency (creatinine clearance 15-29 ml/min), the European Heart Journal suggests considering suspension of enoxaparin at least 36 hours before low-risk bleeding procedures and at least 48 hours before high-risk bleeding procedures 2
For patients receiving neuroaxial anesthesia, the European Society of Anaesthesiology recommends suspending enoxaparin prophylaxis at least 12 hours before the procedure 4

For low-risk bleeding procedures, the American College of Chest Physicians recommends restarting enoxaparin thromboprophylaxis 24 hours after the procedure if adequate hemostasis has been achieved 6, 2
For high-risk bleeding procedures, the World Journal of Emergency Surgery suggests restarting enoxaparin thromboprophylaxis 48-72 hours after the procedure 5, 2

The Journal of Clinical Oncology notes that extended prophylaxis with enoxaparin (up to 4 weeks) after abdominal or pelvic cancer surgery significantly reduces the incidence of venous thromboembolism (VTE) compared to standard prophylaxis (4.8% vs 12.0%) 7

The American College of Chest Physicians warns that suspending enoxaparin too early may increase the risk of perioperative thromboembolic events 1
The Journal of Clinical Oncology notes that failing to restart postoperative prophylaxis increases the risk of VTE, especially in patients undergoing oncologic surgery 7
The European Heart Journal cautions that administering the first postoperative dose too soon (less than 24 hours) may increase the risk of bleeding 4
The European Society of Cardiology advises against using "bridging" with unfractionated heparin in patients receiving enoxaparin prophylaxis, as it unnecessarily increases the risk of bleeding 3, 2